-+ 0.00%
-+ 0.00%
-+ 0.00%

BioCryst Pharma Q4 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $163.284M Beat $151.326M Estimate

Benzinga·02/26/2026 12:38:32
Listen to the news
BioCryst Pharma (NASDAQ:BCRX) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 14.58 percent. This is a 142.31 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $163.284 million which beat the analyst consensus estimate of $151.326 million by 7.90 percent. This is a 24.14 percent increase over sales of $131.534 million the same period last year.